See also this year's filing and all EDGAR filings for this company.
PDF Report 0000811641_2024_Immucell_CORP_DE.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0000811641, Immucell CORP DE
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 14,617,605 |
| 1 | LiabilitiesCurrent | 4,197,420 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 0 |
| 4 | AssetsNoncurrent | 16,040,999 |
| 5 | PropertyPlantAndEquipmentNet | 27,575,683 |
| 6 | Goodwill | 133,765 |
| 7 | remainder_Assets | 57,655 |
| 8 | GeneralAndAdministrativeExpense | 18,824,895 |
| 9 | ResearchAndDevelopmentExpense | 4,394,852 |
| 10 | remainder_Expenses | 4,627 |
| 11 | remainder_Revenues | 17,471,669 |
| 12 | remainder_NetIncome | -21,893 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 18,815,025 |
| 1 | Assets | 43,808,102 |
| 2 | Expenses | 23,224,374 |
| 3 | Revenues | 17,471,669 |
| 4 | StockholdersEquity | 24,993,077 |
| 5 | NetIncome | -5,774,598 |
| 6 | ComprehensiveNetIncome | -5,774,598 |
| 7 | BaseVar | 51,670,532 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.909 |
| 9 | EconomicCapitalRatio | 1.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
